Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
October 14, 2008
MOUNTAIN VIEW, Calif., Oct. 14 -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., applauds the three winners of the 2008 Nobel Prize in Chemistry; Drs. Osamu Shimomura, Martin Chalfie, and Roger Y. Tsien, for the discovery and development of the green fluorescent protein (GFP) and a wide array of related fluorescent proteins. [...]
Mark Sutherland Joins GenVault as Senior Vice President, Business Development
October 14, 2008
CARLSBAD, Calif., Oct. 14 -- GenVault Corporation today announces that Mr. Mark Sutherland has joined GenVault as its Senior Vice President of Business Development. Mr. Sutherland will be responsible for finding, prioritizing and closing significant opportunities for partnering and licensing the company's products and technologies as well as developing a series of strategic alliances. Mr. [...]
TEPNEL EXPANDS GENETIC SERVICES PORTFOLIO WITH ADDITION OF ILLUMINA iScan RAPID READER
October 14, 2008
Tepnel Life Sciences plc ('Tepnel' or 'the Company') Manchester, UK - 14th October 2008 Tepnel Life Sciences PLC (AIM: TED) today announced that it has expanded its molecular genetic services offering through the addition of Illumina's iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. [...]
Expansion Sees Q Chip Move to New Facility
October 14, 2008
Cardiff, UK, 14 October 2008 – Q Chip Ltd, a leading developer of microencapsulation solutions, has officially opened its new corporate headquarters and R&D facility in Cardiff. The expansion into new headquarters marks a significant step in the steady expansion Q Chip has experienced since its foundation. In summer 2007 Q Chip successfully completed a [...]
October 14, 2008
Ludesi Corporation, developer of the award-winning Ludesi Image Analysis Service and the Ludesi REDFIN software for two-dimensional electrophoresis gels, today announced that researchers at the University of Pennsylvania in Philadelphia, National Eye Institute at National Institutes of Health in Bethesda Maryland, and the University of North Carolina at Chapel Hill have been able to discover [...]
MIT and T-Ray Science Conclude IP Agreement
October 14, 2008
VANCOUVER, BRITISH COLUMBIA, Oct 14, 2008 -- T-Ray Science, Inc. ("T-Ray", the "Company"), an emerging leader in the field of TeraHertz ("THz") research, today announced an exclusive patent license agreement has been reached with the Massachusetts Institute of Technology ("MIT"). The license grants T-Ray the exclusive right to produce spectroscopy and imaging systems which utilize [...]
Varian, Inc. Pre-Announces Stronger Than Expected Results
October 14, 2008
Tuesday October 14, 8:00 am ET - Full Year Non-GAAP Diluted EPS Above $2.80 Versus Prior Guidance of $2.74 +/ - $0.05 - Full Year GAAP Diluted EPS Above $2.11 Versus Prior Guidance of $2.05 +/- $0.09 - Sales Above $1 Billion For Full Year - Record Non-GAAP Operating Margins for Fourth Quarter PALO ALTO, [...]
New Axios FAST, the fastest X-ray fluorescence spectrometer available
October 14, 2008
The launch of the new Axios FAST simultaneous XRF system is another landmark achievement for leading X-ray analysis company PANalytical (Almelo, the Netherlands). Advanced, rapid, and easy to use, the Axios FAST is synonymous with the highest levels of accuracy and precision, excellent detection limits, high throughput and maximum uptime. Pioneering technology ensures that Axios [...]
New GC Column Provides Fast, High-Resolution Forensic Drug Testing
October 13, 2008
Torrance, CA (October 13, 2008) – Phenomenex Inc., a global leader in the manufacture of separation science consumables, introduces the Zebron™ ZB-Drug-1 column for GC analysis of drugs of abuse. The Zebron ZB-Drug-1 column is 50% faster than existing technologies and delivers improved resolution of target analytes. Zebron ZB-Drug-1 is a mid-polarity stationary phase that [...]
Affymetrix Announces Preliminary Third Quarter Revenue
October 13, 2008
Affymetrix, Inc. (Nasdaq:AFFX), today reported that based on preliminary financial data, the Company expects total revenue for the third quarter of 2008 to be approximately $75 million. Global sales fell below expectations for the quarter driven by increased competition for academic research funding and continued softness in industrial spending. "We are disappointed with our results [...]
